KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.0000 (0.00%)
At close: 4:15PM EDT
Stock chart is not supported by your current browser
Previous Close3.3000
Bid3.2600 x 0
Ask3.2800 x 0
Day's Range3.2000 - 3.3300
52 Week Range0.8700 - 4.3500
Avg. Volume1,483,650
Market Cap303.839M
Beta (3Y Monthly)3.58
PE Ratio (TTM)N/A
EPS (TTM)-0.4080
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • CNW Group6 days ago

    Khiron Provides Update on Transaction to Acquire NettaGrowth

    TORONTO, May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of the Acquisition.

  • CNW Group8 days ago

    Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders

    Proxy voting deadline is May 29, 2019 at 11 a.m. (Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO, May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials") to Khiron's shareholders ("Shareholders") in connection with the annual general and special meeting of Shareholders (the "Meeting").

  • CNW Group13 days ago

    /C O R R E C T I O N from Source -- Khiron Life Sciences Corp./

    In the news release, Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing, issued 06-May-2019 by Khiron Life Sciences Corp. over CNW, we are advised by the company that the first paragraph, last sentence, should read "Common Share of $2.90" rather than "Common Share of $3.00" as originally issued inadvertently. TORONTO, May 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, announced today that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, on behalf of a syndicate of underwriters (together, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, 8,621,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.90 (the "Issue Price") for gross proceeds of $25,000,900 (the "Offering").

  • Market Exclusive18 days ago

    Cannabis Stock News Daily Roundup May 1

    Panaxia Pharmaceutical Industries Israel and pharmaceutical company Rafa signed a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. Under the agreement, the parties will co-develop the next generation of medical cannabis products intended for patients suffering from Inflammatory Bowel Disease, and who are authorized to receive treatment with medical cannabis. Khiron Life Sciences (TSXV: […]The post Cannabis Stock News Daily Roundup May 1 appeared first on Market Exclusive.

  • CNW Group18 days ago

    Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update

    Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution Became the first Colombian cannabis company to list on the TSX Venture Exchange ...

  • Baystreet19 days ago

    Hemp Beauty Getting Home-Delivery Treatment, as E-Commerce Giant Brings Hemp Offerings to Subscribers

    Subscribers of the world's largest beauty subscription service will soon be joining the cannabis ...